Cite
MLA Citation
S. Tan et al.. “P776: A PHASE 2, OPEN-LABEL, ASCENDING DOSE STUDY OF KER-050 FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES.” HemaSphere, vol. 6, n.d., pp. 671–672. http://access.bl.uk/ark:/81055/vdc_100159756420.0x000005